Elevance Health Inc (ELV) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Elevance Health Announces Appearance at UBS Global Healthcare Conference

Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho...

Elevance Health Appoints Nathan Rich Vice President, Investor Relations

Elevance Health (NYSE: ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In...

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Elevance Health Reports Third Quarter 2024 Results

3Q 2024 operating revenue of $44.7 billion 3Q 2024 adjusted operating gain1 of $2.4 billion 3Q 2024 diluted EPS2 of $4.36; adjusted diluted EPS1...

Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2024 Results on October 17, 2024

Elevance Health (NYSE: ELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”...

Form 4 - Statement of changes in beneficial ownership of securities